This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Americold Realty Trust Inc. (COLD) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Americold Realty Trust (COLD) delivered FFO and revenue surprises of +5.88% and +0.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
COLDNegative Net Change STRWPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ConocoPhillips (COP) Tops Q2 Earnings Estimates
by Zacks Equity Research
ConocoPhillips (COP) delivered earnings and revenue surprises of +4.41% and -1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
COPPositive Net Change EPSNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Insmed (INSM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Insmed (INSM) delivered earnings and revenue surprises of -30.77% and +3.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
INSMPositive Net Change ARCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Appian (APPN) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Appian (APPN) delivered earnings and revenue surprises of +100.00% and +6.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
APPNNegative Net Change DCBONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gogo (GOGO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Gogo (GOGO) delivered earnings and revenue surprises of +8.33% and +2.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GOGOPositive Net Change CMBMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kimbell Royalty (KRP) Lags Q2 Earnings Estimates
by Zacks Equity Research
Kimbell Royalty (KRP) delivered earnings and revenue surprises of -85.71% and +6.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KRPNo Net Change GLNGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
N-able (NABL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
N-able (NABL) delivered earnings and revenue surprises of +22.22% and +4.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NABLNegative Net Change LNZAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Insulet (PODD) delivered earnings and revenue surprises of +25.81% and +5.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PODDPositive Net Change QIPTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
D-Wave Quantum Inc. (QBTS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
D-WAVE QUANTUM (QBTS) delivered earnings and revenue surprises of -816.67% and +22.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
QBTSNegative Net Change AFRMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +2.63% and -0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CCCCNegative Net Change DAREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Crocs (CROX) delivered earnings and revenue surprises of +5.49% and +0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CROXPositive Net Change DLTHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Datadog (DDOG) delivered earnings and revenue surprises of +12.20% and +4.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DDOGNegative Net Change MDBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SolarEdge Technologies (SEDG) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
SolarEdge (SEDG) delivered earnings and revenue surprises of +1.22% and +5.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SEDGPositive Net Change NOVAQNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Warner Bros. Discovery (WBD) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Warner Bros. Discovery (WBD) delivered earnings and revenue surprises of +493.75% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WBDNegative Net Change GTNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Evergy Inc (EVRG) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Evergy (EVRG) delivered earnings and revenue surprises of +7.89% and -1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EVRGPositive Net Change BLDPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hyatt Hotels (H) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Hyatt Hotels (H) delivered earnings and revenue surprises of +3.03% and +3.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HNegative Net Change HTHTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of -3.95% and +8.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PHATPositive Net Change BOLTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cogent Communications (CCOI) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Cogent (CCOI) delivered earnings and revenue surprises of -30.11% and +0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CCOINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Viatris (VTRS) delivered earnings and revenue surprises of +10.71% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VTRSNegative Net Change ICCMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates
by Zacks Equity Research
Warby Parker (WRBY) delivered earnings and revenue surprises of 0.00% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WRBYPositive Net Change OLLINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Martin Marietta (MLM) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Martin Marietta (MLM) delivered earnings and revenue surprises of +2.07% and -0.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MLMNegative Net Change DYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Thermon Group (THR) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Thermon Group (THR) delivered earnings and revenue surprises of -2.70% and -11.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
THRNegative Net Change ADSKNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
US Foods (USFD) Tops Q2 Earnings Estimates
by Zacks Equity Research
US Foods (USFD) delivered earnings and revenue surprises of +4.39% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
USFDPositive Net Change CPBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Aclaris (ACRS) delivered earnings and revenue surprises of 0.00% and +14.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACRSPositive Net Change NTRBNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Janus International Group, Inc. (JBI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Janus International Group (JBI) delivered earnings and revenue surprises of +33.33% and +7.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JBINegative Net Change HOVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank